
Seftos SB 250mg/125mg Injection
Marketer
Smile Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Seftos SB 250mg/125mg Injection
Ceftobiprole (250mg/125mg) injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial, completing the full course even with symptom improvement. Premature cessation may compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects require immediate medical attention. Seek emergency care for allergic reactions such as rash, pruritus, edema, or dyspnea. Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption is discouraged due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and ample hydration are recommended for optimal recovery. Monitoring may involve periodic laboratory tests to assess therapeutic response.
Uses of Seftos SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Seftos SB 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Seftos SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Seftos SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Seftos SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Seftos SB 250mg/125mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering bacterial viability. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Seftos SB 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seftos SB 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials using animal models have revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Seftos SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Seftos SB 250mg/125mg Injection could lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Operation of a motor vehicle should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Seftos SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 250mg/125mg Seftos SB Injection requires careful administration in individuals with advanced liver impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage changes for this injection are unnecessary for patients exhibiting mild or moderate hepatic dysfunction.
What if you forget to take Seftos SB 250mg/125mg Injection :
Omitting a scheduled dose of Seftos SB 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Seftos SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
